Medtronic has acquired ATS Medical, following payment of $4 per share in cash for each share of ATS Medical stock and assumption of net debt, with a total transaction value of approximately $370m.
Medtronic structural heart business vice president and general manager John Liddicoat said that Medtronic is focused on providing innovative solutions for cardiac surgeons and their patients worldwide.
“Our completed purchase of ATS Medical immediately expands Medtronic’s product offerings and pipeline of surgical valves, repair products and surgical ablation technologies,” Liddicoat said.
Medtronic is committed to advance the treatment of structural heart disease through collaboration with leading clinicians, researchers and scientists worldwide.
Headquartered in Minneapolis, Medtronic is a global provider of medical technology alleviating pain, restoring health, and extending life for millions of people around the world.